NasoShield™ (Single Dose Intranasal Anthrax Vaccine)
An intranasal vaccine designed to provide protection against anthrax after a single administration. It is being developed with the support of the U.S. Biomedical Advanced Research and Development Authority, (BARDA) for post-exposure prophylaxis against anthrax following exposure to aerosolized B. anthracis spores.
Availability: In Development
| Manufacturer |
| Altimmune, Inc. |
| Product Name |
| NasoShield™ (Single Dose Intranasal Anthrax Vaccine) |
| Detection Category |
| Biological |
| Detection Method |
| Medical Countermeasure; |
| Application |
| Personal Protective Equipment; |
| Equipment Type |
| PPE |
| Product Synopsis |
| An intranasal vaccine designed to provide protection against anthrax after a single administration. It is being developed with the support of the U.S. Biomedical Advanced Research and Development Authority, (BARDA) for post-exposure prophylaxis against anthrax following exposure to aerosolized B. anthracis spores. |
| Availability |
| In Development |
| Technology Readiness Level (TRL) |
| 7 |
| User Feedback Sources |
| Indifferent/No user feedback |
| Transportability |
| Pocket Size |
| Live Agent Tested |
| Yes; B. anthracis (anthrax) |
| Operating Time |
| Preventative administration prior to exposure |
| Training Required |
| <1 hour training |